DE102010030555A1 - Kit-of-parts, useful for hair treatment, comprises a hair treating composition comprising e.g. alginic acid and calcium lactate packed in a first container, and a caring composition comprising e.g. silicones packed in a second container - Google Patents

Abstract

Kit-of-parts (I) comprises (a) a hair treating composition packed in a first container, and (b) a caring composition packed in a second container, where: (a) comprises ingredients comprising: e.g. alginic acid, ammonium alum, ammonium glycyrrhizate, anhydroxylitol, arachidyl glucoside, ascorbic acid, ascorbyl palmitate, behenyl beeswax, 12-20C alkyl glucoside, calcium alginate, calcium lactate, capryloyl glycine, caprylyl/caprylic glucoside, cetearyl alcohol and cetearyl olivate; and (b) comprises caring materials comprising quaternary ammonium compounds, tertiary amines, and/or silicones. Kit-of-parts (I) comprises (a) a hair treating composition packed in a first container, and (b) a caring composition packed in a second container, where: (a) comprises at least 60 wt.% of ingredients comprising: e.g. Acacia decurrens/jojoba/sunflower seed wax/polyglyceryl-3 ester, alginic acid, ammonium alum, ammonium glycyrrhizate, anhydroxylitol, arachidyl glucoside, ascorbic acid, ascorbyl palmitate, behenyl beeswax, 12-20C alkyl glucoside, calcium alginate, calcium lactate, capryloyl glycine, caprylyl/caprylic glucoside, cellulose, cetearyl alcohol, cetearyl olivate, cetyl palmitate, chitosan, chitosan lactate, cholesterol, coco-glucoside, coconut alcohol, cyclodextrin, decyl glucoside, dehydroxanthan gum, dicaprylyl ether, dipalmitoyl hydroxyproline, disodium cocoyl glutamate, erythrulose, gellan gum, glyceryl behenate, glyceryl caprylate, aluminum stearate, ammonium coco-sulfate, ammonium lauryl sulfate, arachidyl alcohol, arginine, algin, ascorbyl palmitate, behenyl alcohol, 14-22C alcohols, calcium glycerophosphate, and caprylic/capric triglyceride; and (b) comprises at least 10 wt.% of caring materials comprising quaternary ammonium compounds, tertiary amines, and/or silicones. An independent claim is included for a method for hair treatment comprising (i) providing and mixing (a) and (b), and (ii) applying on hair.

Description

The invention relates to natural cosmetic hair treatment compositions that are individually enhanced performance.

Human hair is today treated in a variety of ways with hair cosmetic preparations. These include, for example, the cleansing of hair with shampoos, the care and regeneration with rinses and cures and the bleaching, dyeing and shaping of the hair with dyes, tinting agents, waving agents and styling preparations.

Particularly in the case of hair cleansing, an increased hygiene awareness leads to an ever more frequent cleaning of the hair. In order to be here in addition to optimal cleaning and hair care long-term, the funds used must be particularly mild to the hair and scalp. Although mild surfactants from a wide variety of groups are known per se, these do not yet sufficiently satisfy all consumer wishes. In addition, there is an increasing consumer desire to use "LOHAS" compliant cosmetics. LOHAS is a marketing term that stands for "Lifestyle of Health and Sustainability" and defines a new lifestyle or consumer type that is based on health and sustainability in its consumer behavior.

There is therefore the consumer desire for natural cosmetic products, coupled with the desire to achieve the care performance of conventional means.

The present invention has for its object to provide hair cleansers that satisfy this consumer desire for natural cosmetic compositions and yet are able to achieve excellent care benefits.

It has now been found that an individually meterable care concentrate allows the consumer to determine the proportion of synthetic compounds and the degree of care of the ready-to-use agent itself and thus achieve an individual compromise between naturalness and performance of the agent.

• A) eine in einem ersten Behälter verpackte Haarbehandlungszusammensetzung und
• B) eine in einem zweiten Behälter verpackte Pflegezusammensetzung, wobei – die Haarbehandlungszusammensetzung bezogen auf ihr Gewicht zu mindestens 60 Gew.-% aus Inhaltsstoffen besteht, die aus der Liste der folgenden Stoffe ausgewählt sind:

– Acacia Decurrens/Jojoba/Sunflower – Algin Seed Wax/Polyglyceryl-3 Esters – Alginic Acid – Aluminum Stearate – Ammonium Alum – Ammonium Coco-Sulfate – Ammonium Glycyrrhizate – Ammonium Lauryl Sulfate – Anhydroxylitol – Arachidyl Alcohol – Arachidyl Glucoside – Arginine – Ascorbic Acid – Ascorbyl Dipalmitate – Ascorbyl Palmitate – Behenyl Alcohol – Behenyl Beeswax – Brassica Campestris/Aleurites Fordi Oil Copolymer – C12-20 Alkyl Glucoside – C14-22 Alcohols – Calcium Alginate – Calcium Glycerophosphate – Calcium Lactate – Caprylic/Capric Triglyceride – Capryloyl Glycine – Caprylyl Caprylate – Caprylyl/Capryl Glucoside – – Cellulose – Ceramide – Cetearyl Alcohol – Cetearyl Glucoside – Cetearyl Olivate – Cetyl Alcohol – Cetyl Palmitate – Cetyl Ricinoleate – Chitosan – Chitosan Glycolate – Chitosan Lactate – Chitosan PCA – Cholesterol – Cholesteryl Hydroxystearate – Cl 75470 – Cl 75810 – Coco-Glucoside – Cocoglycerides – Coconut Alcohol – Corn Starch Modified – Cyclodextrin – Decyl Cocoate – Decyl Glucoside – Decyl Oleate – Dehydroxanthan Gum – Dextrin Palmitate – Dicaprylyl Ether – Dihydroxyacetone – Dipalmitoylhydroxyproline – Disodium Coco-Glucoside Citrate – Disodium Cocoyl Glutamate – Distarch Phosphate – Erythrulose – Ethyl Lactate – Gellan Gum – Glucose Glutamate – Glycerin – Glyceryl Abietate – Glyceryl Behenate – Glyceryl Caprate – Glyceryl Caprylate – Glyceryl Citrate/Lactate/Linoleate/Oleate – Glyceryl Dibehenate – Glyceryl Dioleate – Glyceryl Distearate – Glyceryl Glucoside – Glyceryl Lactate – Glyceryl Laurate – Glyceryl Linoleate – Glyceryl Linolenate – Glyceryl Oleate – Glyceryl Oleate Citrate – Glyceryl Ricinoleate – Glyceryl Sorbitan Oleostearate – Glyceryl Stearate – Glyceryl Stearate Citrate – Glyceryl Stearate SE – Glycyrrhetinic Acid – Hydrogenated Apricot Kernel Oil – Hydrogenated Castor Oil – Hydrogenated Coco-Glycerides – Hydrogenated Coconut Oil – Hydrogenated Jojoba Oil – Hydrogenated Jojoba Wax – Hydrogenated Lecithin – Hydrogenated Meadowfoam Seed Oil – Hydrogenated Olive Oil – Hydrogenated Palm Glycerides – Hydrogenated Palm Glycerides Citrate – Hydrogenated Palm Kernel Glycerides – Hydrogenated Palm Oil – Hydrogenated Peanut Oil – Hydrogenated Phosphatidylcholine – Hydrogenated Rapeseed Oil – Hydrogenated Vegetable Oil – Hydrolyzed Algae Extract – Hydrolyzed Beeswax – Hydrolyzed Fibroin – Hydrolyzed Hibiscus Esculentus – Hydrolyzed Jojoba Esters Extract – Hydrolyzed Keratin – Hydrolyzed Lola Implexa Extract – Hydrolyzed Milk Protein – Hydrolyzed Rhizobian Gum – Hydrolyzed Rice Protein – Hydrolyzed Silk – Hydrolyzed Soy Protein – Hydrolyzed Sweet Almond Protein – Hydrolyzed Wheat Gluten – Hydrolyzed Wheat Protein – Hydroxystearic/Linolenic/Linoleic – Hydroxystearic/Linolenic/Oleic Polyglycerides Polyglycerides – Isoamyl Laurate – Isostearyl Hydroxystearate – Jojoba Esters – Lanolin Alcohol – Lauroyl Lysine – Lauryl Alcohol – Lauryl Glucoside – Lauryl Lactate – Lauryl Laurate – Lauryl PCA – Levulinic Acid – Lysolecithin – Magnesium Ascorbyl Phosphate – Magnesium Gluconate – Magnesium Stearate – Maltitol – Maltodextrin – Mannitol – Menthanediol – – Microcrystalline Cellulose – Myristic Acid – Myristyl Alcohol – Myristyl Glucoside – Myristyl Lactate – Myristyl Myristate – Octyldodecanol – Oleyl Alcohol – Oleyl Erucate – Oryzanol – Palm Kernel Acid – Palmitic Acid – Palmityl Alcohol – p-Anisic Acid – PCA – PCA Ethyl Cocoyl Arginate – PCA Glyceryl Oleate – Phytosteryl/Octyldodecyl Lauroyl Glutamate – Polyglyceryl-10 Laurate – Polyglyceryl-2 Caprate – Polyglyceryl-2 Dipolyhydroxystearate – Polyglyceryl-2 Polyhydroxystearate – Polyglyceryl-3 Caprylate – Polyglyceryl-3 Diisostearate – Polyglyceryl-3 Laurate – Polyglyceryl-3 Oleate – Polyglyceryl-3 Palmitate – Polyglyceryl-3 Polyricinoleate – Polyglyceryl-3 Ricinoleate – Polyglyceryl-3 Stearate – Polyglyceryl-4 Caprate – Polyglyceryl-5 Laurate – Polyglyceryl-5 Oleate – Polyglyceryl-6 Caprylate – Polyglyceryl-6 Dicaprate – Polyglyceryl-6 Oleate – Polyglyceryl-6 Stearate – Potassium Cetyl Phosphate – Potassium Cocoate – Potassium Laurate – Potassium Myristate – Potassium Olivate – Potassium Palmitate – Potassium Palmitoyl Hydrolyzed Wheat Protein – Potassium Stearate – Saccharide Isomerate – Sodium Alginate – Sodium Anisate – Sodium Beeswax – Sodium Cetearyl Sulfate – Sodium Cocoate – Sodium Coco-Glucoside Tartrate – Sodium Cocopolyglucose Tartrate – Sodium Coco-Sulfate – Sodium Cocoyl Alaninate – Sodium Cocoyl Amino Acids – Sodium Cocoyl Glutamate – Sodium Cocoyl Hydrolyzed Wheat Protein – Sodium Lauroyl Glutamate – Sodium Lauroyl Lactylate – Sodium Lauryl Sulfate – Sodium Levulinate – Sodium Myristate – Sodium Myristoyl Glutamate – Sodium Oleanolate – Sodium Olivate – Sodium Palm Kernelate – Sodium Palmate – Sodium Palmitate – Sodium PCA – Sodium Phytate – Sodium Stearate – Sodium Stearoyl Glutamate – Sodium Stearoyl Lactylate – Sodium Tallowate – Sodium Ursolate – Sorbitan Laurate – Sorbitan Oleate – Sorbitan Olivate – Sorbitan Palmitate – Sorbitan Sesquicaprylate – Sorbitan Stearate – Sorbitol – Soybean Glycerides – Squalane – Squalene – Stearic Acid – Stearyl Alcohol – Stearyl Beeswax – Sucrose Cocoate – Sucrose Distearate – Sucrose Laurate – Sucrose Palmitate – Sucrose Polystearate – Sucrose Stearate – Sucrose Tristearate – Sulfated Castor Oil – Sunflower Seed Sorbitol Esters – Tocopheryl Acetate – Tribehenin – Tricaprylin – Triethyl Citrate – Undecylenic Acid – Water – Xylitol – Xylitylglucoside – Zinc Citrate – Zinc PCA – Zinc Ricinoleate – Zinc Stearate

• – die Pflegezusammensetzung bezogen auf ihr Gewicht mindestens 10 Gew.-% Pflegestoffe aus den Gruppen der – quarternären Ammoniumverbindungen und/oder – teriären Amine und/oder – Silikone

enthält.The present application in a first embodiment, kit-of-parts, comprising

• A) a hair treatment composition packaged in a first container and
• B) a care composition packaged in a second container, wherein - the hair treatment composition comprises by weight at least 60% by weight of ingredients selected from the list of the following substances:

- Acacia Decurrens / Jojoba / Sunflower - Algin Seed Wax / Polyglyceryl-3 Esters - alginic acid - Aluminum Stearate - Ammonium Alum - Ammonium Coco Sulfate - Ammonium glycyrrhizate - Ammonium Lauryl Sulfate - Anhydroxylitol - Arachidyl alcohol - Arachidyl glucosides - Arginine - ascorbic acid - ascorbyl dipalmitate - ascorbyl palmitate - Behenyl Alcohol - Behenyl Beeswax - Brassica Campestris / Aleurites Fordi Oil Copolymer C12-20 alkyl glucosides - C14-22 Alcohols - Calcium alginates - Calcium glycerophosphates - Calcium lactates - Caprylic / Capric triglycerides - Capryloyl Glycine - Caprylyl Caprylate - Caprylyl / caprylic glucosides - - cellulose - Ceramides - Cetearyl alcohol - Cetearyl glucosides - Cetearyl Olivate - Cetyl Alcohol - Cetyl palmitate - Cetyl ricinoleates - Chitosan - Chitosan Glycolate - chitosan lactate - Chitosan PCA - Cholesterol - Cholesteryl hydroxystearates - Cl 75470 - Cl 75810 - coco-glucosides - cocoglycerides - Coconut Alcohol - Corn Starch Modified - Cyclodextrin - Decyl Cocoate - Decyl glucosides - Decyl Oleate - Dehydroxanthan gum - Dextrin Palmitate - dicaprylyl ether - Dihydroxyacetones - dipalmitoylhydroxyproline - Disodium Coco-Glucosides Citrate - Disodium cocoyl glutamate - Distarch Phosphates - Erythrulose - Ethyl lactates - Gellan Gum - Glucose Glutamate - glycerin - Glyceryl Abietate - Glyceryl behenate - Glyceryl caprate - Glyceryl caprylates - glyceryl Citrate / Lactate / linoleate / oleate - Glyceryl dibehenate - Glyceryl dioleate - Glyceryl distearate - Glyceryl glucosides - Glyceryl lactates - glyceryl laurate - Glyceryl linoleates - Glyceryl linolenates - Glyceryl Oleate - Glyceryl Oleate Citrate - Glyceryl ricinoleates - Glyceryl sorbitan oleostearates - Glyceryl Stearate - Glyceryl Stearate Citrate - Glyceryl Stearate SE - Glycyrrhetinic acid - Hydrogenated Apricot Kernel Oil - Hydrogenated Castor Oil - Hydrogenated Coco-Glycerides - Hydrogenated Coconut Oil - Hydrogenated Jojoba Oil - Hydrogenated Jojoba Wax - Hydrogenated lecithin - Hydrogenated Meadowfoam Seed oil - Hydrogenated Olive Oil - Hydrogenated Palm Glycerides - Hydrogenated Palm Glycerides Citrate - Hydrogenated Palm Kernel Glycerides - Hydrogenated Palm Oil - Hydrogenated Peanut Oil - Hydrogenated phosphatidylcholines - Hydrogenated Rapeseed Oil - Hydrogenated Vegetable Oil - Hydrolyzed Algae Extract - Hydrolyzed Beeswax - Hydrolyzed fibroin - Hydrolyzed Hibiscus Esculentus - Hydrolyzed Jojoba Esters Extract - Hydrolyzed keratin - Hydrolyzed Lola Implexa Extract - Hydrolyzed Milk Protein - Hydrolyzed Rhizobian Gum - Hydrolyzed rice protein - Hydrolyzed Silk - Hydrolyzed soy protein - Hydrolyzed Sweet Almond protein - Hydrolyzed Wheat Gluten - Hydrolyzed Wheat Protein - Hydroxystearic / Linolenic / Linoleic - Hydroxystearic / Linolenic / Oleic Polyglycerides Polyglycerides - Isoamyl Laurate - Isostearyl hydroxystearates - Jojoba Esters - Lanolin Alcohol - lauroyl lysine - Lauryl Alcohol - Lauryl Glucoside - Lauryl Lactates - Lauryl Laurate - Lauryl PCA - levulinic acid - lysolecithin - Magnesium ascorbyl phosphate - Magnesium Gluconate - Magnesium Stearate - Maltitol - maltodextrin - mannitol - menthanediol - - Microcrystalline cellulose - Myristic acid - myristyl alcohol - myristyl glucoside - myristyl lactate - myristyl myristate - Octyl dodecanol - Oleyl Alcohol - oleyl erucate - Oryzanol - Palm Kernel Acid - Palmitic Acid - Palmityl Alcohol P-anisic acid - PCA - PCA Ethyl Cocoyl Arginate - PCA Glyceryl Oleate - phytosteryl / octyldodecyl Lauroyl Glutamate Polyglyceryl-10 Laurate - Polyglyceryl-2 caprate - Polyglyceryl-2 dipolyhydroxystearates - polyglyceryl-2 polyhydroxystearate - Polyglyceryl-3-caprylates - Polyglyceryl-3 diisostearate Polyglyceryl-3 Laurate - Polyglyceryl-3 oleates - Polyglyceryl-3 palmitates - Polyglyceryl-3 Polyricinoleates - Polyglyceryl-3 ricinoleates - Polyglyceryl-3 stearates - Polyglyceryl-4 Caprate Polyglyceryl-5 Laurate - Polyglyceryl-5 oleates - Polyglyceryl-6-caprylates - Polyglyceryl-6 dicaprate - Polyglyceryl-6 oleates - polyglyceryl-6 stearates - Potassium Cetyl Phosphate - Potassium Cocoate - Potassium Laurate - Potassium myristate - Potassium Olivate - Potassium Palmitate - Potassium Palmitoyl Hydrolyzed Wheat Protein - Potassium Stearate - saccharides isomerates - Sodium alginate - Sodium anisate - Sodium Beeswax - Sodium Cetearyl Sulfate - Sodium Cocoate - Sodium Coco-Glucoside tartrate - Sodium cocopolyglucose tartrate - Sodium coco sulphate - Sodium cocoyl alaninate - Sodium Cocoyl Amino Acids - Sodium Cocoyl Glutamate - Sodium Cocoyl Hydrolyzed Wheat protein - Sodium Lauroyl Glutamate - Sodium Lauroyl Lactylate - Sodium Lauryl Sulfate - Sodium Levulinate - Sodium myristate - Sodium myristoyl glutamate - Sodium Oleanolate - Sodium Olivate - Sodium Palm Kernelate - Sodium Palmate - Sodium Palmitate - Sodium PCA - Sodium Phytate - Sodium stearate - Sodium stearoyl glutamate - Sodium stearoyl lactylate - Sodium Tallowate - Sodium Ursolate - Sorbitan Laurate - Sorbitan Oleate - Sorbitan Olivate - Sorbitan Palmitate - sorbitan sesquicaprylate - Sorbitan Stearate - sorbitol - soybean glycerides - Squalane - Squalene - Stearic acid - Stearyl alcohol - stearyl beeswax - sucrose cocoate - Sucrose distearate - sucrose laurate - sucrose palmitate - sucrose polystearates - sucrose stearate - sucrose tristearate - Sulfated Castor Oil - Sunflower Seed Sorbitol Esters - tocopheryl acetate - Tribehenin - tricaprylin - triethyl citrate - undecylenic acid - Water - xylitol - xylitylglucosides - Zinc Citrate - Zinc PCA - Zinc Ricinoleate - Zinc Stearate

• - The care composition based on their weight at least 10 wt .-% care agents from the groups of - quaternary ammonium compounds and / or - teriary amines and / or - silicones

contains.

The kit-of-parts according to the invention comprises at least one hair treatment composition packaged in a first container and at least one packaged in a second container Care composition. In addition, the kit according to the invention may comprise further components, in particular an instruction manual which explains the use of the kit according to the invention. The kit according to the invention is preferably designed and packaged for home use.

The "kit" of the invention comprises at least a first container containing a hair treatment composition and at least one second container containing a conditioning composition. These two containers with their respective contents are connected to one another in the kit-of-parts according to the invention.

In the context of the present invention, "connected to one another" means any mechanism for making it clear to a consumer or user that the two containers, together with the compositions contained in them, form a unit, are associated with one another and should be used in combination.

"Connected together" therefore means, for example, the joint packaging and the joint sale of both containers with the compositions contained within them within a common outer packaging. Alternatively, both containers can be sold separately with the compositions contained in them, wherein a common marketing concept recommends sharing the consumer. This compound may exist in gifts, incentive packs or other consumer benefits when purchasing both products, but may also be achieved by mapping the particular other product onto the product packaging. Last but not least, joint advertising for both products or corresponding consumer advice is also possible. The kit-of-parts according to the invention is realized in the latter case by the purchase of both products by the consumer.

According to the invention, a kit of parts is preferred in which both containers with the compositions contained in them are present within a common outer packaging.

The instructions for use contained in the kit according to the invention may also be present in non-physical, for example electronic, form, for example as an Internet page or as spoken instructions, which can be called up by telephone. The addition of data carriers, such as CD-ROMs or floppy disks, memory sticks, etc. is possible.

According to the invention, the kit comprises at least a first container containing a hair treatment composition. The term "container" in this case denotes a recording option, regardless of their shape, material or closure, which includes the ability to include substances or mixtures of substances. The term "container" therefore includes, but is not limited to, tubes, bags or sacks, canisters, cans, bottles, etc.

The hair treatment composition packaged in a first container is at least 60% by weight, based on its weight, of ingredients selected from the list of substances mentioned above. Preferred kits according to the invention are characterized in that the hair treatment composition is at least 70% by weight, preferably at least 75% by weight, more preferably at least 80% by weight, particularly preferably at least 85% by weight, based on its weight. , more preferably at least 90 wt .-% and in particular at least 99 wt .-% consists of ingredients that are selected from the list of substances mentioned in claim 1.

Preferably, the hair treatment composition packaged in a first container is a natural cosmetic. Natural cosmetics are products that are exclusively made of natural materials, subject to the exceptions listed below. Natural substances are substances of botanical, inorganic-mineral or animal origin (except dead vertebrates) as well as their mixtures and reaction products among themselves. Only physical processes (including extraction) and pH adjusters are authorized for recovery and further processing. In addition, enzymatic and microbiological processes are permitted when only naturally occurring enzymes or microorganisms are used. The treatment of plant and animal raw materials as well as the end product with ionizing radiation is not permitted. Bleaching of natural products is permitted, but not using chlorine (sodium hypochlorite).

In natural cosmetics, those natural fragrances (essential oils) can be used, which are the ISO standard 9235 correspond. This includes isolates of essential oils as well as of them reconstructed essential oils. Synthetic nature-identical fragrances and chemically modified natural fragrances must not be used in natural cosmetics.

The origin of the water used in natural cosmetics is arbitrary. In the calculation of the natural product content of the finished product, this is considered in any case only as a natural product, if it comes directly from a vegetable source (directly derived plant juices).

Natural preservatives may be used for the preservation of natural cosmetics [subject to the conditions set out in Annex VI (first part) of Directive 76/768 / EEC]. Moreover, nature-identical inorganic pigments and minerals can be used in natural cosmetics.

For the production of natural cosmetics otherwise only natural substances may be used, which are obtained by chemical reaction starting from natural substances as defined in Section A. 1. a (eg fats, oils, waxes, lecithins, mono-, oligo- and polysaccharides, Proteins, lipoproteins). The following chemical reactions are permitted: hydrolysis (including saponification), neutralization, condensation with elimination of water, esterification, transesterification, hydrogenation, hydrogenolysis, dehydrogenation, glycosylation, phosphorylation, sulfation, acylation, amidation, oxidation (with oxygen, ozone and peroxides ) and pyrolysis. Near-natural substances also include other substances which, although they occur naturally, can not be obtained from their natural sources in sufficient quantities according to the respective state of the art.

According to the invention, the kit further comprises at least a second container containing a care composition. The term "container" again denotes a receptacle, regardless of its shape, material or closure, which includes the possibility to include substances or mixtures of substances. The term "container" therefore includes, but is not limited to, tubes, bags or sacks, canisters, cans, bottles, etc.

• – quarternären Ammoniumverbindungen und/oder
• – teriären Amine und/oder
• – Silikone.

The packaged in a second container care composition contains - based on their weight - at least 10 wt .-% care agents from the groups of

• - Quaternary ammonium compounds and / or
• - Teriary Amines and / or
• - silicones.

These substances will be described below.

Preferred quaternary ammonium compounds are ammonium halides, in particular chlorides and bromides, such as alkyltrimethylammonium chlorides, dialkyldimethylammonium chlorides and trialkylmethylammonium chlorides. The long alkyl chains of these surfactants preferably have 10 to 18 carbon atoms, such as. In cetyl trimethyl ammonium chloride, stearyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride, lauryl dimethyl ammonium chloride, lauryl dimethyl benzyl ammonium chloride and tricetylmethyl ammonium chloride. Further preferred cationic surfactants are the imidazolium compounds known under the INCI names Quaternium-27 and Quaternium-83.

• – Alkyltrimethylammoniumchloriden mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Dialkyldimethylammoniumchloride mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Trialkylmethylammoniumchloride mit vorzugsweise 10 bis 18 Kohlenstoffatomen im Alkylrest und/oder
• – Cetyltrimethylammoniumchlorid und/oder
• – Stearyltrimethylammoniumchlorid und/oder
• – Distearyldimethylammoniumchlorid und/oder
• – Lauryldimethylammoniumchlorid und/oder
• – Lauryldimethylbenzylammoniumchlorid und/oder
• – Tricetylmethylammoniumchlorid
• – Quaternium-27 und/oder
• – Quaternium-83 und/oder
• – N-Methyl-N(2-hydroxyethyl)-N,N-(ditalgacyloxyethyl)ammonium-methosulfat und/oder
• – N-Methyl-N(2-hydroxyethyl)-N,N-(distearoyloxyethyl)ammonium-methosulfat und/oder
• – N,N-Dimethyl-N,N-distearoyloxyethyl-ammoniumchlorid und/oder
• – N,N-Di-(2-hydroxyethyl)-N,N-(fettsäureesterethyl)-ammoniumchlorid.

Particularly preferred kits according to the invention are characterized in that the care composition contains 0.5 to 30 wt .-%, preferably 1 to 25 and in particular 2.5 to 10 wt .-% quartenary ammonium compound (s) based on their weight. Preferred QAV is / are selected from

• - Alkyltrimethylammoniumchloriden having preferably 10 to 18 carbon atoms in the alkyl radical and / or
• - Dialkyldimethylammoniumchloride having preferably 10 to 18 carbon atoms in the alkyl radical and / or
• - Trialkylmethylammoniumchloride preferably having 10 to 18 carbon atoms in the alkyl radical and / or
• Cetyltrimethylammonium chloride and / or
• Stearyltrimethylammonium chloride and / or
• Distearyldimethylammonium chloride and / or
• - Lauryldimethylammonium chloride and / or
• - Lauryldimethylbenzylammoniumchlorid and / or
• - tricetylmethylammonium chloride
• - Quaternium-27 and / or
• - Quaternium-83 and / or
• - N-methyl-N (2-hydroxyethyl) -N, N- (ditalgacyloxyethyl) ammonium methosulfate and / or
• - N-methyl-N (2-hydroxyethyl) -N, N- (distearoyloxyethyl) ammonium methosulfate and / or
• - N, N-dimethyl-N, N-distearoyloxyethyl ammonium chloride and / or
• - N, N-di (2-hydroxyethyl) -N, N- (fatty acid ethyl) ammonium chloride.

Very particularly preferred kits according to the invention are characterized in that the care composition QAV of the formula (I) R ^I ₂ N ⁺ (R ^II ) _x (R ^II ) _y X ^- (I) contains, in the
R ^I for long-chain fatty acid residues, preferably stearoyl or cocoyl,
R ^{II is} an alkyl radical, preferably (CH ₂ ) _n CH ₃ ,
R ^{III is} a hydroxyalkyl radical, preferably (CH ₂ CH ₂ OH),
n is an integer, preferably 2,
x and y are 0, 1 or 2, where x + y = 2 and
X is an anion, preferably methosulfate.

In addition to or in place of the QAC, the care compositions contained in the kit of the invention may contain tertiary amines, especially amidoamines. It is further advantageous if amidoamine is used in concentrations of 1.5 to 2.5 wt .-% (based on the weight of the care composition). It is preferred if the cationic surfactant used is an amidoamine, particularly preferably stearamidopropyl dimethylamine. This leads to an improvement in the volume of the hairstyle or the treated arrangement of the keratinic fibers. As another amidoamines stearamidopropyldimethylamines, Stearamidopropyldiethylamine, Stearamidoethyldiethylamine, Stearamidoethyldimethylamine, Palmitamidopropyldimethilamine, Palmitamidopropyldiethilamine, Palmitamidoethyldiethilamine, Palmitamidoethyldimethilamine, Behenamidopropyldimethylamine, Behenamidopropyldiethylamine, Behenamidoethyldiethylamine, Behenamidoethyldimethylamine, Arachidamidopropyldimethylamine, Arachidamidopropyldiethylamine, Arachidamidoethyldiethylamine, Arachidamidoethyldimethylamine can be used.

In addition to or in place of the QAC and / or the tertiary amines, the care compositions contained in the kit of the invention may contain silicones. Kits preferred according to the invention are characterized in that the care composition contains 2.5 to 60% by weight, preferably 5 to 50 and in particular 10 to 40% by weight of silicone (s), based on their weight.

• (i) Polyalkylsiloxanen, Polyarylsiloxanen, Polyalkylarylsiloxanen, die flüchtig oder nicht flüchtig, geradkettig, verzweigt oder cyclisch, vernetzt oder nicht vernetzt sind;
• (ii) Polysiloxanen, die in ihrer allgemeinen Struktur eine oder mehrere organofunktionelle Gruppen enthalten, die ausgewählt sind unter: a) substituierten oder unsubstituierten aminierten Gruppen; b) (per)fluorierten Gruppen; c) Thiolgruppen; d) Carboxylatgruppen; e) hydroxylierten Gruppen; f) alkoxylierten Gruppen; g) Acyloxyalkylgruppen; h) amphoteren Gruppen; i) Bisulfitgruppen; j) Hydroxyacylaminogruppen; k) Carboxygruppen; l) Sulfonsäuregruppen; und m) Sulfat- oder Thiosulfatgruppen;
• (iii) linearen Polysiloxan(A)-Polyoxyalkylen(B)-Blockcopoylmeren vom Typ (A-B)_n mit n > 3;
• (iv) gepfropften Siliconpolymeren mit nicht siliconhaltigem, organischen Grundgerüst, die aus einer organischen Hauptkette bestehen, welche aus organischen Monomeren gebildet wird, die kein Silicon enthalten, auf die in der Kette sowie gegebenenfalls an mindestens einem Kettenende mindestens ein Polysiloxanmakromer gepfropft wurde;
• (v) gepfropften Siliconpolymeren mit Polysiloxan-Grundgerüst, auf das nicht siliconhaltige, organische Monomere gepfropft wurden, die eine Polysiloxan-Hauptkette aufweisen, auf die in der Kette sowie gegebenenfalls an mindestens einem ihrer Enden mindestens ein organisches Makromer gepfropft wurde, das kein Silicon enthält;

oder deren Gemischen.Preferred care compositions according to the invention are characterized in that they contain at least one silicone, preferably a silicone, which is selected from:

• (i) polyalkyl siloxanes, polyaryl siloxanes, polyalkylaryl siloxanes which are volatile or nonvolatile, straight chain, branched or cyclic, crosslinked or uncrosslinked;
• (ii) polysiloxanes containing in their general structure one or more organofunctional groups selected from: a) substituted or unsubstituted aminated groups; b) (per) fluorinated groups; c) thiol groups; d) carboxylate groups; e) hydroxylated groups; f) alkoxylated groups; g) acyloxyalkyl groups; h) amphoteric groups; i) bisulfite groups; j) hydroxyacylamino groups; k) carboxy groups; l) sulfonic acid groups; and m) sulfate or thiosulfate groups;
• (iii) linear polysiloxane (A) polyoxyalkylene (B) block copolymers of the (AB) _{n type} with n>3;
• (iv) grafted silicone polymers having a non-silicone organic backbone consisting of an organic backbone formed from organic monomers containing no silicone grafted with at least one polysiloxane macromer in the chain and optionally at least one chain end;
• (v) grafted polysiloxane backbone silicone polymers having grafted thereto non-silicone organic monomers having a polysiloxane backbone to which at least one organic macromer not containing silicone has been grafted in the chain, and optionally at least at one of its ends ;

or their mixtures.

Care compositions which are particularly preferred according to the invention contain the silicone (s) preferably in amounts of from 0.1 to 10% by weight, preferably from 0.25 to 7% by weight and in particular from 0.5 to 5% by weight. , in each case based on the total care composition.

Preferred silicones are described below.

Particularly preferred care compositions according to the invention are characterized in that they contain at least one silicone of the formula Si-I (CH ₃ ) ₃ Si- [O-Si (CH ₃ ) ₂ ] _x -O-Si (CH ₃ ) ₃ (Si-I), in which x is a number from 0 to 100, preferably from 0 to 50, more preferably from 0 to 20 and in particular 0 to 10.

These silicones are called DIMETHICONE according to the INCI nomenclature. In the context of the present invention, as the silicone of the formula Si-1, the compounds are preferably:
(CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₃ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₀ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₁ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₂ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₃ -Q-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₄ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₅ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₇ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₆ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₁₉ -O-Si (CH ₃ ) ₃
(CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂₀ -O-Si (CH ₃ ) ₃
where (CH ₃ ) ₃ Si-O-Si (CH ₃ ) ₃ , (CH ₃ ) ₃ Si-O- (CH ₃ ) ₂ Si-O-Si (CH ₃ ) ₃ and / or (CH ₃ ) ₃ Si [O- (CH ₃ ) ₂ Si] ₂ -O-Si (CH ₃ ) _{3 are} particularly preferred.

Of course, mixtures of o. G. Silicones be included in the care compositions of the invention.

Preferred silicones which can be used according to the invention have viscosities of from 0.2 to 2 mm ² s ^-1 at 20 ° C., silicones having viscosities of from 0.5 to 1 mm ² s ^{-1 being} particularly preferred.

Particularly preferred care compositions according to the invention contain one or more amino-functional silicones. Such silicones may, for. B. by the formula M (R _a Q _b SiO _{(4-ab) / 2) x} (R _c SiO _{(4-c) / 2) y} M wherein R in the above formula is a hydrocarbon or a hydrocarbon radical having from 1 to about 6 carbon atoms, Q is a polar radical of the general formula -R ¹ HZ wherein R ^{1 is} a is a divalent connecting group bonded to hydrogen and the radical Z, composed of carbon and hydrogen atoms, carbon, hydrogen and oxygen atoms or carbon, hydrogen and nitrogen atoms, and Z is an organic, amino-functional radical which is at least contains an amino-functional group; "A" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 1 to about 3, "a" + "b" is less than or equal to 3, and "c" is a number in the range from about 1 to about 3, and x is a number ranging from 1 to about 2,000, preferably from about 3 to about 50, and most preferably from about 3 to about 25, and y is a number ranging from about 20 to about 10,000 , preferably from about 125 to about 10,000, and most preferably from about 150 to about 1,000, and M is a suitable silicone end group as known in the art, preferably trimethylsiloxy. Non-limiting examples of the groups represented by R include alkyl groups such as methyl, ethyl, propyl, isopropyl, isopropyl, butyl, isobutyl, amyl, isoamyl, hexyl, isohexyl and the like; Alkenyl radicals such as vinyl, halovinyl, alkylvinyl, allyl, haloallyl, alkylallyl; Cycloalkyl radicals such as cyclobutyl, cyclopentyl, cyclohexyl and the like; Phenyl radicals, benzyl radicals, halohydrocarbon radicals such as 3-chloropropyl, 4-bromobutyl, 3,3,3-trifluoropropyl, chlorocyclohexyl, bromophenyl, chlorophenyl and the like, and sulfur-containing radicals such as mercaptoethyl, mercaptopropyl, mercaptohexyl, mercaptophenyl and the like; preferably R is an alkyl radical containing from 1 to about 6 carbon atoms, and most preferably R is methyl. Examples of R ¹ include methylene, ethylene, propylene, hexamethylene, decamethylene, -CH ₂ CH (CH ₃ ) CH ₂ -, phenylene, naphthylene, -CH ₂ CH ₂ SCH ₂ CH ₂ -, -CH ₂ CH ₂ OCH ₂ - , -OCH ₂ CH ₂ -, -OCH ₂ CH ₂ CH ₂ -, -CH ₂ CH (CH ₃ ) C (O) OCH ₂ -, - (CH ₂ ) ₃ CC (O) OCH ₂ CH ₂ -, C ₆ H ₄ C ₆ H ₄ -, -C ₆ H ₄ CH ₂ C ₆ H ₄ -; and - (CH ₂ ) ₃ C (O) SCH ₂ CH ₂ -.

Z is an organic, amino-functional radical containing at least one functional amino group. A possible formula for Z is NH (CH ₂ ) _z NH ₂ , wherein z is 1 or more. Another possible formula for Z is -NH (CH ₂ ) _Z (CH ₂ ) ₆ NH, wherein both z and zz are independently 1 or more, this structure comprising diamino ring structures, such as piperazinyl. Z is most preferably a -NHCH ₂ CH ₂ NH ₂ radical. Another possible formula for Z is -N (OH ₂ ) _z (OH ₂ ) _zz NX ₂ or -NX ₂ , wherein each X of X _{2 is} independently selected from the group consisting of hydrogen and alkyl groups of 1 to 12 carbon atoms, and zz is 0.

Q is most preferably a polar, amine functional group of the formula -CH ₂ CH ₂ CH ₂ NHCH ₂ CH ₂ NH ₂ . In the formulas, "a" assumes values in the range of about 0 to about 2, "b" assumes values in the range of about 2 to about 3, "a" + "b" is less than or equal to 3, and "c "Is a number in the range of about 1 to about 3. The molar ratio of the R _a Q _b SiO _{(4-ab) / 2} units to the R _c SiO _{(4-c) / 2} units is in the range of about 1: 2 to 1:65, preferably from about 1: 5 to about 1:65, and most preferably from about 1:15 to about 1:20. When one or more silicones of the above formula are used, the various variable substituents in the above formula may be different for the various silicone components present in the silicone blend.

• – G ist -H, eine Phenylgruppe, -OH, -O-CH₃, -CH₃, -O-CH₂CH₃, -CH₂CH₃, -O-CH₂CH₂CH₃, -CH₂CH₂CH₃, -O-CH(CH₃)₂, -CH(CH₃)₂, -O-CH₂CH₂CH₂CH₃, -CH₂CH₂CH₂CH₃, -O-CH₂CH(CH₃)₂, -CH₂CH(CH₃)₂, -O-CH(CH₃)CH₂CH₃, -CH(CH₃)CH₂CH₃, -O-C(CH₃)₃, -C(CH₃)₃
• – a steht für eine Zahl zwischen 0 und 3, insbesondere 0;
• – b steht für eine Zahl zwischen 0 und 1, insbesondere 1,
• – m und n sind Zahlen, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt,
• – R' ist ein monovalenter Rest ausgewählt aus – -Q-N(R'')-CH₂-CH₂-N(R'')₂ – -Q-N⁺(R'')₃A^– – -Q-N⁺H(R'')₂A^– – -Q-N⁺H₂(R'')A^– – -Q-N(R'')-CH₂-CH₂-N⁺R''H₂A^–, wobei jedes Q für eine chemische Bindung, -CH₂-, -CH₂-CH₂-, -CH₂CH₂CH₂-, -C(CH₃)₂-, -CH₂CH₂CH₂CH₂-, -CH₂C(CH₃)₂-, -CH(CH₃)CH₂CH₂- steht, R'' für gleiche oder verschiedene Reste aus der Gruppe -H, -Phenyl, -Benzyl, -CH₂-CH(CH₃)Ph, der C_1-20-Alkylreste, vorzugsweise -CH₃, -CH₂CH₃, -CH₂CH₂CH₃, -CH(CH₃)₂, -CH₂CH₂CH₂H₃, -CH₂CH(CH₃)₂, -CH(CH₃)CH₂CH₃, -C(CH₃)₃, steht und A ein Anion repräsentiert, welches vorzugsweise ausgewählt ist aus Chlorid, Bromid, Iodid oder Methosulfat.

Preferred care compositions according to the invention are characterized in that they contain an amino-functional silicone of the formula (Si-II) R _'a G _3-a -Si (OSiG _{2) n} - (OSiG _b R' _{2-b) m} -O-SiG _3-a -R _'a (Si-II), contain, in which means:

• G is -H, a phenyl group, -OH, -O-CH ₃ , -CH ₃ , -O-CH ₂ CH ₃ , -CH ₂ CH ₃ , -O-CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -O-CH (CH ₃ ) ₂ , -CH (CH ₃ ) ₂ , -O-CH ₂ CH ₂ CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₂ CH ₃ , -O-CH ₂ CH (CH ₃ ) ₂ , -CH ₂ CH (CH ₃ ) ₂ , -O-CH (CH ₃ ) CH ₂ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -OC (CH ₃ ) ₃ , -C (CH ₃ ) ₃
• A is a number between 0 and 3, in particular 0;
• B is a number between 0 and 1, in particular 1,
• M and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n is preferably values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10,
• R 'is a monovalent radical selected from - -QN (R ") - CH ₂ -CH ₂ -N (R") ₂ - -QN ⁺ (R ") ₃ A ^- - -QN ⁺ H (R '') ₂ A ^- - -QN ⁺ H ₂ (R '') A ^- - -QN (R '') - CH ₂ -CH ₂ -N ⁺ R''H ₂ A ^- , where each Q is a chemical Bond, -CH ₂ -, -CH ₂ -CH ₂ -, -CH ₂ CH ₂ CH ₂ -, -C (CH ₃ ) ₂ -, -CH ₂ CH ₂ CH ₂ CH ₂ -, -CH ₂ C (CH ₃ ) ₂ -, -CH (CH ₃ ) CH ₂ CH ₂ -, R '' is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , -C ( CH ₃ ) ₃ , and A represents an anion, which is preferably selected from chloride, bromide, iodide or methosulfate.

enthalten, worin m und n Zahlen sind, deren Summe (m + n) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei n vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Particularly preferred care compositions according to the invention are characterized in that they contain at least one amino-functional silicone of the formula (Si-IIa)

in which m and n are numbers whose sum (m + n) is between 1 and 2000, preferably between 50 and 150, where n preferably values of 0 to 1999 and in particular of 49 to 149 and m preferably values of 1 to 2000 , in particular from 1 to 10 assumes.

These silicones are referred to as trimethylsilylamodimethicones according to the INCI declaration.

enthalten, worin R für -OH, -O-CH₃ oder eine -CH₃-Gruppe steht und m, n1 und n2 Zahlen sind, deren Summe (m + n1 + n2) zwischen 1 und 2000, vorzugsweise zwischen 50 und 150 beträgt, wobei die Summe (n1 + n2) vorzugsweise Werte von 0 bis 1999 und insbesondere von 49 bis 149 und m vorzugsweise Werte von 1 bis 2000, insbesondere von 1 bis 10 annimmt.Care compositions according to the invention which are particularly preferred are also an amino-functional silicone of the formula (Si-IIb)

in which R is -OH, -O-CH ₃ or a -CH ₃ group and m, n1 and n2 are numbers whose sum (m + n1 + n2) is between 1 and 2,000, preferably between 50 and 150 , where the sum (n1 + n2) preferably assumes values from 0 to 1999 and in particular from 49 to 149 and m preferably values from 1 to 2000, in particular from 1 to 10.

These silicones are referred to as amodimethicones according to the INCI declaration.

Regardless of which amino-functional. Silicone are used, care compositions according to the invention are preferred which contain an amino-functional silicone whose amine number is above 0.25 meq / g, preferably above 0.3 meq / g and in particular above 0.4 meq / g. The amine number stands for the milliequivalents of amine per gram of the amino-functional silicone. It can be determined by titration and also expressed in mg KOH / g.

Care compositions which are preferred according to the invention are characterized in that, based on their weight, they contain 0.01 to 10% by weight, preferably 0.1 to 8% by weight, particularly preferably 0.25 to 7.5% by weight and in particular from 0.5 to 5% by weight of amino-functional silicone (s).

enthalten, in der x für eine Zahl von 3 bis 200, vorzugsweise von 3 bis 10, weiter bevorzugt von 3 bis 7 und insbesondere 3, 4, 5 oder 6, steht.The INCI CYCLOMETHICONE designated cyclic dimethicones are inventively used with preference. Here care compositions according to the invention are preferred, the at least one silicone of the formula Si-III

in which x is a number from 3 to 200, preferably from 3 to 10, more preferably from 3 to 7 and in particular 3, 4, 5 or 6 stands.

The silicones described above have a backbone composed of -Si-O-Si units. Of course, these Si-O-Si units may also be interrupted by carbon chains. Appropriate molecules are accessible by chain extension reactions and are preferably used in the form of silicone-in-water emulsions.

Care compositions which are likewise preferred according to the invention are characterized in that they contain at least one silicone of the formula Si-IV R ₃ Si [O-SiR ₂ ] _x - (CH ₂ ) _n - [O-SiR ₂ ] _y -O-SiR ₃ (Si-IV), in which R is identical or different radicals from the group -H, -phenyl, -benzyl, -CH ₂ -CH (CH ₃ ) Ph, the C _1-20 -alkyl radicals, preferably -CH ₃ , -CH ₂ CH ₃ , -CH ₂ CH ₂ CH ₃ , -CH (CH ₃ ) ₂ , -CH ₂ CH ₂ CH ₂ H ₃ , -CH ₂ CH (CH ₃ ) ₂ , -CH (CH ₃ ) CH ₂ CH ₃ , - C (CH ₃ ) ₃ , x and y are a number from 0 to 200, preferably from 0 to 10, more preferably from 0 to 7 and especially 0, 1, 2, 3, 4, 5 or 6, stand and n is a number from 0 to 10, preferably from 1 to 8 and in particular from 2, 3, 4, 5, 6.

The silicones are preferably water-soluble. Care compositions preferred according to the invention are characterized in that they contain at least one water-soluble silicone.

The care effects of the care compositions contained in the kit according to the invention can be further enhanced by using certain care substances. These are preferably selected from certain groups of known care substances, since these care substances perfectly harmonize with the substances used according to the invention in terms of formulation and the care effect.

• i. L-Carnitin und/oder seiner Salze;
• ii. Panthenol und/oder Panthothensäure;
• iii. der 2-Furanone und/oder deren Derivate, insbesondere Pantolacton;
• iv. Taurin und/oder seiner Salze;
• v. Niacinamid;
• vi. Ubichinon
• vii. Ectoin;
• viii. Allantoin.

Care compositions which are preferred according to the invention are characterized in that they additionally contain care substance (s) in amounts of from 0.001 to 10% by weight, preferably from 0.005 to 7.5% by weight, particularly preferably from 0.01 to 5% by weight % and in particular 0.05 to 2.5 wt .-%, with preferred care substance (s) are selected from the group

• i. L-carnitine and / or its salts;
• ii. Panthenol and / or panthothenic acid;
• iii. the 2-furanones and / or their derivatives, in particular pantolactone;
• iv. Taurine and / or its salts;
• v. niacinamide;
• vi. ubiquinone
• vii. Ectoin;
• viii. Allantoin.

In care compositions of this embodiment contained in the kit according to the invention at least one care substance is used which is selected from L-carnitine and / or its salts, panthenol and / or pantothenic acid, 2-furanones and / or their derivatives, in particular pantolactone, taurine and / or its Salts, niacinamide, ubiquinones, ectoine, allantoin. These conditioners are described below

L-carnitine (IUPAC name (R) - (3-carboxy-2-hydroxypropyl) -N, N, N-trimethylammonium hydroxide) is a naturally occurring, vitamin-like substance. It plays an essential role in the energy metabolism of human, animal and plant cells. L-carnitine can be obtained in various ways on an industrial scale. For example, a, the body's own biosynthesis imitating, biotechnological process: In large fermentation tanks while the precursor of L-carnitine (γ-butyrobetaine) using Gram-negative bacteria (rhizobia) is converted into L-carnitine.

As betaine, L-carnitine can form addition compounds and double salts. L-carnitine derivatives which are preferred according to the invention are selected in particular from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and particularly preferably L-carnitine tartrate. The L-carnitine compounds mentioned are available, for example, from Lonza GmbH (Wuppertal, Germany).

Preferred care compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.005 to 7.5% by weight, particularly preferably from 0.01 to 5% by weight and in particular 0.05 contain up to 2.5 wt .-% L-carnitine or L-carnitine derivatives, with preferred L-carnitine derivatives are selected from acetyl-L-carnitine, L-carnitine fumarate, L-carnitine citrate, lauroyl-L-carnitine and in particular L-carnitine tartrate.

Panthenol (IUPAC name: (+) - (R) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide) is converted to pantothenic acid in the body. Pantothenic acid is a vitamin from the group of B vitamins (vitamin B5).

Preferred care compositions according to the invention are characterized in that they contain, based on their weight, from 0.01 to 5% by weight, preferably from 0.05 to 2.5% by weight, particularly preferably from 0.1 to 1.5% by weight. % and in particular 0.25 to 1 wt .-% of panthenol ((±) -2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethyl-butyramide).

in welchen die Reste R¹ bis R¹⁰ unabhängig voneinander stehen für:

• – Wasserstoff, -OH, einen Methyl-, Methoxy-, Aminomethyl- oder Hydroxymethylrest,
• – -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -NR¹²R¹³, wobei R¹² und R¹³ jeweils unabhängig voneinander stehen für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -CONR¹⁵R¹⁶, wobei R¹⁵ und R¹⁶ jeweils stehen für Wasserstoff, Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxykohlenwasserstoffrest, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyaminokohlenwasserstoffrest,

mit der Maßgabe, dass für den Fall, wenn R⁷ und R⁸ für -OH und gleichzeitig R⁹ oder R¹⁰ für Wasserstoff stehen, die verbleibende Gruppe R⁹ oder R¹⁰ nicht für einen Dihydroxyethylrest steht.Care compositions which are preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5% by weight and in particular 0.5 to 5% by weight of at least one 2-furanone derivative of the formula (Fur-I) and / or of the formula (Fur-II)

in which the radicals R ¹ to R ¹⁰ are independently:

• Hydrogen, -OH, a methyl, methoxy, aminomethyl or hydroxymethyl radical,
• --C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or Trihydroxykohlenwasserstoffrest,
• --C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -NR ¹² R ¹³ , wherein R ¹² and R ¹³ each independently represent hydrogen, a methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbyl radical,
• - a group -CONR ¹⁵ R ¹⁶ , wherein R ¹⁵ and R ¹⁶ each represent hydrogen, methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ - saturated mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbon hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• A group -COR ¹⁶ , where R ¹⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or -or- or di-unsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxy hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical,

with the proviso that for the case when R ⁷ and R ^{8 are} -OH and at the same time R ⁹ or R ^{10 is} hydrogen, the remaining group R ⁹ or R ^{10 is} not a dihydroxyethyl radical.

The compounds of the formulas (Fur-I) and (Fur-II) are used as intermediates in the synthesis of natural products and in the preparation of medicaments and vitamins. The preparation of the active compounds according to the formulas (Fur-I) and (Fur-II) can be carried out, for example, by reacting primary alcohols with acrylic acids. Furthermore, compounds of the formula (Fur-I) are obtained by reactions starting from Hydroxypivaldehyde. Also, carbonylations of alkynes lead to substituted 2-furanones of the formula (Fur-I) or (Fur-II). Finally, the compounds of the formula (Fur-I) or of the formula (Fur-II) can be obtained by intramolecular esterification of the corresponding hydroxycarboxylic acids. For example, the following compounds are obtained in one of the previously identified synthetic routes: 2,5-dihydro-5-methoxy-2-furanone, tetrahydro-5-oxo-2-furancarboxylic acid, dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone, or 3,4-dimethyl-5-pentylidenedihydro-2 (5H) -furanone or 4-hydroxy-2,5-dimethyl-3 (2H) -furanone. The 2-furanones contained in the kit according to the invention include of course all possible stereoisomers as well as their mixtures. The 2-furanones present in the kit according to the invention do not have a lasting effect on the odor of the cosmetic care compositions, so that perfuming of the care compositions must take place separately.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -NR¹²R¹³, wobei R¹² und R¹³ jeweils unabhängig voneinander stehen für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxyalkylrest, oder einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyaminokohlenwasserstoffrest.

Preferred compounds of the formula (fur-I) and / or of the formula (fur-II) may be compounds in which the substituents R ¹ , R ² and R ⁷ independently of one another represent:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• A C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -NR ¹² R ¹³ , wherein R ¹² and R ¹³ each independently represent hydrogen, a methyl, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , wherein R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or - or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• A group -COR ¹⁶ , where R ¹⁶ is a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated or -or- or di-unsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical, a -C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or polyhydroxyalkyl radical, or a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear mono-, di-, tri- or polyamino hydrocarbon radical.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.

In a further embodiment of the teaching according to the invention, it has been found that in the case of the compounds of the formula (Fur-I) or of the formula (Fur-II), the radicals R ³ , R ⁴ and R ^{8 are} preferably, independently of one another,

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest oder
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Triaminokohlenwasserstoffrest.

Furthermore, it may be preferred for the radicals R ⁵ , R ⁶ , R ⁹ and R ¹⁰ in the active ingredient according to the formula (I) and / or the formula (II) contained in the kit according to the invention to stand independently of one another

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear hydrocarbon radical,
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical or
• - a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear mono-, di- or triaminocarbon.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄- gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COR¹⁶, wobei R¹⁶ steht für einen Methyl-, einen -C₂C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- oder Polyhydroxykohlenwasserstoffrest.

In a particularly preferred embodiment of the teaching according to the invention, a compound of the formula (Fur-I) is used. In this case, it may be preferred that in a compound of the formula (fur-I) the radicals R ¹ and R ² independently of one another represent:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -COR ¹⁶ , wherein R ¹⁶ is a methyl, a -C ₂ C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ - saturated or one or two times unsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- or Polyhydroxykohlenwasserstoffrest.

• – Wasserstoff, einen -OH-, einen Methyl-, Methoxy-, Aminomethyl-, Hydroxymethylrest,
• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -COOR¹⁴, wobei R¹⁴ steht für Wasserstoff, einen Methyl-, einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₄ – gesättigten ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OCOR¹⁷, wobei R¹⁷ steht für einen Methyl-, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, einen -C₂-C₃₀ – gesättigten oder ein- oder mehrfach ungesättigten, verzweigten oder linearen Mono-, Di-, Tri- und/oder Polyhydroxykohlenwasserstoffrest.

Furthermore, in this particularly preferred embodiment of the teaching according to the invention, it may be advantageous if in the compounds of the formula (Fur-I) the radicals R ³ and R ⁴ independently of one another represent:

• Hydrogen, an -OH, a methyl, methoxy, aminomethyl, hydroxymethyl radical,
• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbyl radical,
• A group -COOR ¹⁴ , where R ¹⁴ is hydrogen, a methyl, a C ₂ -C ₄ -saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₄ -saturated hydrocarbon radical, or diunsaturated, branched or linear mono-, di- or trihydroxyhydrocarbyl radical,
• - a group -OCOR ¹⁷ , wherein R ¹⁷ is a methyl, a -C ₂ -C ₃₀ -saturated or mono- or polyunsaturated, branched or linear hydrocarbon radical, a -C ₂ -C ₃₀ -saturated or one or polyunsaturated, branched or linear mono-, di-, tri- and / or polyhydroxy hydrocarbon radical.

• – einen -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest,
• – eine Gruppe -OR¹¹, mit R¹¹ als einem -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Kohlenwasserstoffrest, -C₂-C₄ – gesättigten oder ein- oder zweifach ungesättigten, verzweigten oder linearen Mono-, Di- oder Trihydroxykohlenwasserstoffrest.

In this preferred embodiment, it may furthermore be advantageous for the compounds of the formula (Fur I) for the radicals R 5 and R 6 to stand independently for:

• A C ₂ -C ₄ saturated or mono- or diunsaturated, branched or linear mono-, di- or trihydroxy hydrocarbon radical,
• - a group -OR ¹¹ , with R ¹¹ as a -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear hydrocarbon radical, -C ₂ -C ₄ - saturated or mono- or diunsaturated, branched or linear Mono-, di- or trihydroxyhydrocarbon radical.

• – (R)-(–)-4-Hydroxymethyl-ϒ-butyrolacton und/oder
• – D,L-4-Hydroxymethyl-γ-butyrolacton und/oder
• – (S)-(+)-4-Hydroxymethyl-γ-butyrolacton und/oder
• – R-(–)-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – D,L-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – S(+)-2-Hydroxy-3,3-dimethyl-γ-butyrolacton und/oder
• – 4-Hydroxy-2,5-dimethyl-3(2H)-furanon und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure, Na-Salz und/oder
• – Tetrahydro-5-oxo-2-furancarbonsäure, K-Salz und/oder
• – 2,5-Dihydro-5-methoxy-2-furanon und/oder
• – Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanon

eingesetzt. In einer ganz besonders bevorzugten Ausführungsform der erfindungsgemäßen Lehre wird als Verbindung entsprechend der Formel (Fur-I) Dihydro-3-hydroxy-4,4-dimethyl-2(3H)-furanon eingesetzt.In a particularly preferred embodiment of the teaching according to the invention is used as the compound according to the formula (Fur-I)

• - (R) - (-) - 4-hydroxymethyl-Υ-butyrolactone and / or
• - D, L-4-hydroxymethyl-γ-butyrolactone and / or
• - (S) - (+) - 4-hydroxymethyl-γ-butyrolactone and / or
• - R - (-) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• - D, L-2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• - S (+) - 2-hydroxy-3,3-dimethyl-γ-butyrolactone and / or
• 4-hydroxy-2,5-dimethyl-3 (2H) -furanone and / or
• - Tetrahydro-5-oxo-2-furancarbonsäure and / or
• - Tetrahydro-5-oxo-2-furancarbonsäure, Na salt and / or
• Tetrahydro-5-oxo-2-furancarboxylic acid, K salt and / or
• 2,5-dihydro-5-methoxy-2-furanone and / or
• Dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone

used. In a very particularly preferred embodiment of the teaching according to the invention is used as a compound corresponding to the formula (Fur-I) dihydro-3-hydroxy-4,4-dimethyl-2 (3H) -furanone.

Another, more preferably usable care substance which has activating properties is taurine. Care compositions which are preferred according to the invention contain, based on their weight, from 0.01 to 15% by weight, preferably from 0.025 to 12.5% by weight, particularly preferably from 0.05 to 10% by weight, more preferably from 0.1 to 7 , 5 wt .-% and in particular 0.5 to 5 wt .-% taurine (2-aminoethanesulfonic acid).

Another preferred group of care agents in the care compositions contained in the kit according to the invention are vitamins, provitamins or vitamin precursors. These are described below:
The group of substances called vitamin A includes retinol (vitamin A ₁ ) and 3,4-didehydroretinol (vitamin A ₂ ). The β-carotene is the provitamin of retinol. As vitamin A component according to the invention, for example, vitamin A acid and its esters, vitamin A aldehyde and vitamin A alcohol and its esters such as the palmitate and the acetate into consideration. The care compositions contained in the kit of the invention contain the vitamin A component preferably in amounts of 0.05-1 wt .-%, based on the total preparation.

• – Vitamin B₁ (Thiamin)
• – Vitamin B₂ (Riboflavin)
• – Vitamin B₃. Unter dieser Bezeichnung werden häufig die Verbindungen Nicotinsäure und Nicotinsäureamid (Niacinamid) geführt. Erfindungsgemäß bevorzugt ist das Nicotinsäureamid, das in den erfindungsgemäß verwendeten Pflegezusammensetzungen bevorzugt in Mengen von 0,05 bis 1 Gew.-%, bezogen auf das gesamte Pflegezusammensetzungen, enthalten ist.
• – Vitamin B₅ (Pantothensäure, Panthenol und Pantolacton). Im Rahmen dieser Gruppe wird bevorzugt das Panthenol und/oder Pantolacton eingesetzt (siehe weiter unten). Erfindungsgemäß einsetzbare Derivate des Panthenols sind insbesondere die Ester und Ether des Panthenols sowie kationisch derivatisierte Panthenole. Einzelne Vertreter sind beispielsweise das Panthenoltriacetat, der Panthenolmonoethylether und dessen Monoacetat sowie die in der WO 92/13829 offenbarten kationischen Panthenolderivate. Die genannten Verbindungen des Vitamin B₅-Typs sind in den im erfindungsgemäßen Kit enthaltenen Pflegezusammensetzungen bevorzugt in Mengen von 0,05–10 Gew.-%, bezogen auf das gesamte Pflegezusammensetzungen, enthalten. Mengen von 0,1–5 Gew.-% sind besonders bevorzugt.
• – Vitamin B₆ (Pyridoxin sowie Pyridoxamin und Pyridoxal).

The vitamin B group or the vitamin B complex include, among others

• - Vitamin B ₁ (thiamine)
• - Vitamin B ₂ (riboflavin)
• - Vitamin B ₃ . Under this name, the compounds nicotinic acid and nicotinamide (niacinamide) are often performed. Preferred according to the invention is the nicotinic acid amide, which is preferably present in the care compositions used according to the invention in amounts of from 0.05 to 1% by weight, based on the total care composition.
• - Vitamin B ₅ (pantothenic acid, panthenol and pantolactone). Panthenol and / or pantolactone are preferably used in the context of this group (see below). Derivatives of panthenol which can be used according to the invention are, in particular, the esters and ethers of panthenol and also cationically derivatized panthenols. Individual representatives are for example the Panthenoltriacetat, the Panthenolmonoethylether and its monoacetate as well as in the WO 92/13829 disclosed cationic panthenol derivatives. The said compounds of the vitamin B ₅ type are preferably contained in the care compositions contained in the kit according to the invention in amounts of 0.05-10% by weight, based on the total care compositions. Amounts of 0.1-5 wt .-% are particularly preferred.
• - Vitamin B ₆ (pyridoxine and pyridoxamine and pyridoxal).

Vitamin C (ascorbic acid). Vitamin C is preferably used in the care compositions contained in the kit according to the invention in amounts of 0.1 to 3 wt .-%, based on the total care compositions. Use in the form of palmitic acid ester, glucosides or phosphates may be preferred. The use in combination with tocopherols may also be preferred.

Vitamin E (tocopherols, especially α-tocopherol). Tocopherol and its derivatives, which include in particular the esters such as the acetate, the nicotinate, the phosphate and the succinate, are preferably present in the care compositions of the invention in amounts of 0.05-1% by weight, based on the total care compositions , contain.

Vitamin F. The term "vitamin F" is usually understood as meaning essential fatty acids, in particular linoleic acid, linolenic acid and arachidonic acid.

Vitamin H. Vitamin H is the compound (3aS, 4S, 6aR) -2-oxohexahydrothienol [3,4-d] -imidazole-4-valeric acid, for which, however, the trivial name biotin has meanwhile become established. Biotin is preferably contained in the care compositions of the present invention in amounts of from 0.0001 to 1.0% by weight, in particular from 0.001 to 0.01% by weight.

In summary, care compositions according to the invention are preferred which, based on their weight, are more preferably 0.1 to 5% by weight, preferably 0.2 to 4% by weight, particularly preferably 0.25 to 3.5% by weight Contain 0.5 to 3 wt .-% and in particular 0.5 to 2.5 wt .-% vitamins and / or pro-vitamins and / or vitamin precursors, preferably the groups A, B, C, E, F and H. Preferred care compositions are 2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutyramide, provitamin B ₅ ) and / or pantothenic acid (vitamin B ₃ , vitamin B ₅ ) and / or niacin , Niacinamide or nicotinamide (vitamin B ₃ ) and / or L-ascorbic acid (vitamin C) and / or thiamine (vitamin B ₁ ) and / or riboflavin (vitamin B ₂ , vitamin G) and / or biotin (vitamin B ₇ , Vitamin H) and / or folic acid (vitamin B ₉ , vitamin B _c or vitamin M) and / or vitamin B ₆ and / or vitamin B ₁₂ .

enthalten in der
X, Y, Z stehen unabhängig voneinander für -O- oder -NH- oder NR⁴- oder eine chemische Bindung
R¹, R², R³ stehen unabhängig voneinander für ein Wasserstoffatom oder eine gegebenenfalls substituierte Arylgruppe oder eine gegebenenfalls substituierte (C₁-C₆)-Alkylgruppe oder eine Hydroxyalkylgruppe oder eine Polyhydroxyalkylgruppe oder eine gegebenenfalls substituierte (C₁-C₆)-Alkylengruppe, oder einen (C₁-C₆)-Acylrest, wobei bevorzugte Reste unabhängig voneinander ausgewählt sind aus -H, -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
R⁴ steht für -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
n steht für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10.It has been shown that certain quinones have a special suitability as a care substance. As a further care substance, the care compositions contained in the kit according to the invention can therefore contain from 0.0001 to 5% by weight of at least one biochinone of the formula (Ubi)

contained in the
X, Y, Z are independently -O- or -NH- or NR ⁴ - or a chemical bond
R ¹ , R ² , R ³ independently of one another represent a hydrogen atom or an optionally substituted aryl group or an optionally substituted (C ₁ -C ₆ ) -alkyl group or a hydroxyalkyl group or a polyhydroxyalkyl group or an optionally substituted (C ₁ -C ₆ ) - Alkylene group, or a (C ₁ -C ₆ ) -acyl radical, preferred radicals being selected independently of one another from -H, -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
R ⁴ is -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
n stands for values from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.

in denen
R¹, R², R³ stehen jeweils unabhängig voneinander für -H, -CH₃, -CH₂CH₃, -(CH₂)₂CH₂, -CH(CH₃)₂, -(CH₂)₃CH₃, -CH(CH₃)CH₂CH₃, -CH₂CH(CH₃)₂, -C(CH₃)₃
R⁴ steht für -CH₃, oder -CH₂CH₃, oder -(CH₂)₂CH₂, oder -CH(CH₃)₂
n steht für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10.Preferred compounds of the formula (Ubi) according to the invention are, for example

in which
R ¹ , R ² , R ³ are each independently -H, -CH ₃ , -CH ₂ CH ₃ , - (CH ₂ ) ₂ CH ₂ , -CH (CH ₃ ) ₂ , - (CH ₂ ) ₃ CH ₃ , -CH (CH ₃ ) CH ₂ CH ₃ , -CH ₂ CH (CH ₃ ) ₂ , -C (CH ₃ ) ₃
R ⁴ is -CH ₃ , or -CH ₂ CH ₃ , or - (CH ₂ ) ₂ CH ₂ , or -CH (CH ₃ ) ₂
n stands for values from 1 to 20, preferably from 2 to 15 and in particular for 5, 6, 7, 8, 9, 10.

in der n für die Werte = 6, 7, 8, 9 oder 10, besonders bevorzugt für 10 (Coenzym Q10) steht.Particularly preferred care compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.0001 to 1 wt .-%, preferably 0.001 to 0.5 wt .-% and particularly preferably 0.005 to 0.1 wt .-% contain at least one ubiquinone and / or at least one ubiquinol and / or at least one derivative of these substances, preferred care compositions containing a ubiquinone of the formula (Ubi)

in which n stands for the values = 6, 7, 8, 9 or 10, particularly preferably 10 (coenzyme Q10).

in der n für Werte von 1 bis 20, vorzugsweise von 2 bis 15 und insbesondere für 5, 6, 7, 8, 9, 10 steht, wobei besonders bevorzugt Pflegezusammensetzungen Plastochinon PQ-9 der Formel

enthalten.As an alternative to the particularly preferred ubiquinones or in addition to them, the care compositions contained in the kit according to the invention may also contain plastoquinones. Here, preferred care compositions according to the invention are characterized in that they are from 0.0002 to 4% by weight, preferably from 0.0005 to 3% by weight, particularly preferably from 0.001 to 2% by weight, more preferably from 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% of at least one plastoquinone of the formula (Ubi-b)

in which n is from 1 to 20, preferably from 2 to 15 and in particular from 5, 6, 7, 8, 9, 10, particularly preferably care compositions Plastochinon PQ-9 of the formula

contain.

As a further care enhancer, the care compositions contained in the kit according to the invention may contain ectoin. Ectoine ((4S) -2-methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic acid) is a natural product belonging to the group of compatible solutes. The highly water-binding low molecular weight organic compound occurs in halophilic bacteria and allows these extremophilic organisms to survive under stress conditions. Care compositions which are preferred according to the invention are characterized in that they contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular 0 , 1 to 1% by weight of (S) -2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (ectoine) and the physiologically tolerated salts of this compound and / or (S, S) -5- Hydroxy-2-methyl-1,4,5,6-tetrahydro-4-pyrimidinecarboxylic acid (hydroxyectoine) and the physiologically acceptable salts of this compound.

Another remedy is allantoin. Allantoin (5-ureidohydantoin, N- (2,5-dioxo-4-imidazolidinyl) urea) is the final product of nucleic acid degradation, especially purine, in various animal species, especially mammals.

Allantoin is used in cosmetics in skin creams, sunscreen care compositions, shaving lotions, toothpaste and in anti-perspiration (hyperhidrosis) and skin irritant care compositions. It accelerates cell building, cell formation or cell regeneration and calms the skin. The healing of hard-healing wounds is also supported, but allantoin has no antiseptic properties.

According to the invention, particularly preferred care compositions contain, based on their weight, from 0.001 to 10% by weight, preferably from 0.01 to 5% by weight, particularly preferably from 0.05 to 2.5% by weight and in particular from 0.1 to 1 5% ureidohydantoin (allantoin).

In order to improve the elasticity and strengthen the internal structure of the hair care hair care compositions contained in the kit according to the invention, the care compositions contained in the kit according to the invention may contain purine and / or purine derivatives as a care substance. In particular, the combination of purine and / or purine derivatives with ubiquinones and / or plastoquinones as a care substance means that the hairs treated with corresponding care compositions show, inter alia, higher measured values in differential thermal analysis and improved wet and dry combabilities.

Purine (7H-imidazo [4,5-d] pyrimidine) does not occur freely in nature, but forms the main body of purines. Purines, in turn, are a group of important compounds naturally involved in human, animal, plant and microbial metabolic processes which are different from the parent by substitution with OH, NH ₂ , SH at the 2-, 6-, and 8-positions and / or with CH ₃ in 1-, 3-, 7-position derived. Purine can be prepared, for example, from aminoacetonitrile and formamide. Purines and purine derivatives are often isolated from natural products, but are also synthetically accessible in many ways.

Preferred care compositions according to the invention contain purine and / or purine derivatives in narrower ranges. Here, preferred cosmetic care compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and in particular from 0.01 to 0.1% by weight of purine (s) and / or purine derivative (s).

in der die Reste R¹, R² und R³ unabhängig voneinander ausgewählt sind aus -H, – OH, NH₂, -SH und die Reste R⁴, R⁵ und R⁶ unabhängig voneinander ausgewählt sind aus -H, -CH₃ und -CH₂-CH₃, wobei folgende Verbindungen bevorzugt sind:

• – Purin (R¹ = R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – Adenin (R¹ = NH₂, R² = R³ = R⁴ = R₅ = R₆ = H)
• – Guanin (R¹ = OH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Harnsäure (R¹ = R² = R³ = OH, R⁴ = R⁵ = R⁶ = H)
• – Hypoxanthin (R¹ = OH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Purinthiol (R¹ = SH, R² = R³ = R⁴ = R⁵ = R⁶ = H)
• – 6-Thioguanin (R¹ = SH, R² = NH₂, R³ = R⁴ = R⁵ = R⁶ = H)
• – Xanthin (R¹ = R² = OH, R³ = R⁴ = R⁵ = R⁶ = H)
• – Coffein (R¹ = R² = OH, R³ = H, R⁴ = R⁵ = R⁶ = CH₃)
• – Theobromin (R¹ = R² = OH, R³ = R⁴ = H, R⁵ = R⁶ = CH₃)
• – Theophyllin (R¹ = R² = OH, R³ = H, R⁴ = CH₃, R⁵ = CH₃, R⁶ = H).

Among purine, the purines and the purine derivatives, some representatives are particularly preferred according to the invention. Care compositions which are preferred according to the invention are characterized in that they contain as care substance - based on their weight - from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight and contains in particular 0.01 to 0.1 wt .-% purine (s) and / or purine derivative (s), wherein preferred care compositions purine and / or purine derivative (s) of the formula (Pur-I)

in which the radicals R ¹ , R ² and R ^{3 are} independently selected from -H, - OH, NH ₂ , -SH and the radicals R ⁴ , R ⁵ and R ^{6 are} independently selected from -H, -CH ₃ and -CH ₂ -CH ₃ , where the following compounds are preferred:

• Purine (R ¹ = R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Adenine (R ¹ = NH ₂ , R ² = R ³ = R ⁴ = R ₅ = R ₆ = H)
• Guanine (R ¹ = OH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Uric acid (R ¹ = R ² = R ³ = OH, R ⁴ = R ⁵ = R ⁶ = H)
• Hypoxanthine (R ¹ = OH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-purethiol (R ¹ = SH, R ² = R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• 6-thioguanine (R ¹ = SH, R ² = NH ₂ , R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Xanthine (R ¹ = R ² = OH, R ³ = R ⁴ = R ⁵ = R ⁶ = H)
• Caffeine (R ¹ = R ² = OH, R ³ = H, R ⁴ = R ⁵ = R ⁶ = CH ₃ )
• - Theobromine (R ¹ = R ² = OH, R ³ = R ⁴ = H, R ⁵ = R ⁶ = CH ₃ )
• Theophylline (R ¹ = R ² = OH, R ³ = H, R ⁴ = CH ₃ , R ⁵ = CH ₃ , R ⁶ = H).

It is also advantageous to use purine or purine derivatives and biochinones in a certain ratio to each other. Care compositions according to the invention are preferred in which the weight ratio of purine (derivative (s)) and biochinone (s) is 10: 1 to 1: 100, preferably 5: 1 to 1:50, particularly preferably 2: 1 to 1:20 and especially 1: 1 to 1:10.

As already mentioned, caffeine is a particularly preferred purine derivative, and coenzyme Q10 is a particularly preferred biochinone. Particularly preferred care compositions of the invention are therefore characterized in that they - based on their weight - from 0.001 to 2.5 wt .-%, preferably 0.0025 to 1 wt .-%, particularly preferably 0.005 to 0.5 wt .-% and in particular 0.01 to 0.1 wt .-% caffeine and 0.0002 to 4 wt .-%, preferably 0.0005 to 3 wt .-%, particularly preferably 0.001 to 2 wt .-%, more preferably 0.0015 to 1 and in particular 0.002 to 0.5 wt .-% coenzyme Q10 included.

As a care substance, the care compositions contained in the kit according to the invention may also contain flavonoids. The flavonoids are a group of water-soluble plant dyes and play an important role in the metabolism of many plants. They belong together with the phenolic acids to the polyphenols. There are well over 6500 different flavonoids known, which can be divided into flavonols, flavones, flavanones, isoflavonoids and anthocyanins.

According to the invention flavonoids from all six groups can be used, with certain representatives from the individual groups are preferred as a care substance because of their particularly intense action. Preferred flavonols are quercetin, rutin, kaempferol, myricetin, isorhamnetin, preferred flavanols are catechin, gallocatechin, epicatechin, epigallocatechin gallate, theaflavin, thearubigin, preferred flavones are luteolin, apigenin, morin, preferred flavanones are hesperetin, naringenin, eriodictyol, preferred isoflavonoids are genistein , Daidzein, and preferred anthocyanidins (anthocyanins) are cyanidin, delphinidin, malvidin, pelargonidin, peonidin, petunidin.

Particularly preferred care compositions according to the invention are characterized in that they contain, based on their weight, from 0.001 to 2.5% by weight, preferably from 0.0025 to 1% by weight, particularly preferably from 0.005 to 0.5% by weight, and in particular 0.01 to 0.1% by weight of flavonoids, in particular flavonols, more preferably 3,3 ', 4', 5,7-pentahydroxyflavone (quercetin) and / or 3,3 ', 4', 5,7-pentahydroxyflavone -3-O-rutinoside (rutin), included.

enthalten.Preference is also the use of bisabolol and / or bisabololoxides as a care substance in the care compositions contained in the kit according to the invention. Care compositions according to the invention which additionally contain 0.001 to 5 wt.%, Preferably 0.01 to 4 wt.%, Particularly preferably 0.02 to 2.5 wt.% And in particular 0.1 to 1.5 wt % Bisabolol and / or oxides of bisabolol, preferably (-) - alpha-bisabolol

contain.

Creatine is also suitable as a care substance according to the invention. Creatine (3-methylguanidinoacetic acid) is an organic acid found in vertebrates and the like. a. contributes to supplying the muscles with energy. Creatine is synthesized in the kidney, liver and pancreas. It is formally derived from the amino acids glycine and arginine and is 95% present in skeletal muscle. Particularly preferred care compositions according to the invention contain - based on their weight - 0.01 to 15 wt .-%, preferably 0.025 to 12.5 wt .-%, particularly preferably 0.05 to 10 wt .-%, more preferably 0.1 to 7.5 wt .-% and in particular 0.5 to 5 wt .-% N-methylguanidino-acetic acid (creatine).

The care compositions included in the kit of the invention may contain, in addition to the ingredients and optional further ingredients listed above, other substances that prevent, ameliorate or cure hair loss. In particular, a content of hair root stabilizing agents is advantageous. These substances are described below: Propecia (finasteride) is currently the only preparation that is approved worldwide and has been proven in many studies to be effective and tolerable. Propecia causes less DHT to form from testosterone.

Minoxidil, with or without supplemental ingredients, is arguably the oldest proven hair growth care composition. For the treatment of hair loss, it may only be used for external application. There are hair lotions containing 2% -5% minoxidil, as well as gels with up to 15% minoxidil. The effectiveness increases with the dosage, in hair waters Minoxidil is only up to 5% share soluble. In many countries, hair tonic with up to 2% minoxidil content is available without prescription.

To combat the hormonal effects on hair follicles, spironolactone in the form of hair tonic and in combination with minoxidil can be used for external application. Spironolactone acts as an androgen receptor blocker, i. H. the binding of DHT to the hair follicles is prevented.

In summary, care compositions according to the invention are preferred which additionally contain, based on their weight, from 0.001 to 5% by weight of hair root stabilizing substances, in particular minoxidil and / or finasteride and / or ketoconazole.

Additional antidandruff active ingredients (for example climbazole, piroctone olamine or zinc pyrithione) are used to purposefully reduce the amount of dandruff causing the dandruff, to restore the normal bacterial count to the normal percentage and to reduce the scaling to the physiological level. However, laboratory tests have shown that the different species representatives of Pityrosporum ovale react differently to the antidandruff active ingredients. In order to maximally combat all dandruff is therefore a combination of anti-dandruff active ingredients most successful.

In summary, care compositions according to the invention which additionally comprise, based on their weight, from 0.001 to 5% by weight of antidandruff active ingredients, in particular piroctone oleamines (1-hydroxy-4-methyl-6- (2,4,4-tri-methylpentyl) -pyridine-2 ( 1H) -one, compound with 2-aminoethanol, 1: 1) and / or zinc pyrithione and / or selenium sulfide and / or climbazole and / or salicylic acid or fumaric acid.

In addition to the care substances, the care compositions contained in the kit according to the invention may contain further care substances. Their presence is not absolutely necessary for achieving the effects according to the invention, but further effects, such as a pleasant touch or a pleasant application feel, can result from the use of these care substances.

As a further ingredient, the care compositions contained in the kit according to the invention may with particular preference contain one or more amino acids. Amino acids which can be used particularly preferably according to the invention are selected from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine-sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline ( L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, whereby both the individual amino acids and mixtures can be used.

Preferred care compositions according to the invention contain one or more amino acids in narrower ranges. Here, according to the invention, preferred care compositions are characterized in that they contain as care substance based on their weight - 0.01 to 5 wt .-%, preferably 0.02 to 2.5 wt .-%, particularly preferably 0.05 to 1.5 Wt .-%, more preferably 0.075 to 1 wt .-% and in particular 0.1 to 0.25 wt .-% amino acid (s), preferably from the group of glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.

As a further component, the care compositions contained in the kit of the invention may contain at least one carbohydrate from the group of monosaccharides, disaccharides and / or oligosaccharides. Here, preferred care compositions according to the invention are characterized in that they contain as care substance - based on their weight - 0.01 to 5 wt .-%, preferably 0.05 to 4.5 wt .-%, particularly preferably 0.1 to 4 wt. -%, more preferably 0.5 to 3.5 wt .-% and in particular 0.75 to 2.5 Wt .-% of carbohydrate (s) selected from monosaccharides, disaccharides and / or oligosaccharides containing preferred carbohydrates are selected from

• - Monosaccharides, in particular D-ribose and / or - D-xylose and / or - L-arabinose and / or D-glucose and / or - D-mannose and / or D-galactose and / or - D-fructose and / or - sorbose and / or - L-fucose and / or - L-rhamnose
• - Disaccharides, in particular - sucrose and / or - maltose and / or - lactose and / or - Trehalose and / or Cellobiose and / or - Gentiobiose and / or - Isomaltose.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose.

Particularly preferred care compositions according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose.

As already mentioned, preferred care compositions according to the invention contain (a) amino acid (s).

Amino acids which can be used particularly preferably according to the invention are selected from the group glycine, alanine, valine, leucine, isoleucine, phenylalanine, tyrosine, tryptophan, proline, aspartic acid, glutamic acid, asparagine, glutamine, serine, threonine, cysteine, methionine, lysine, arginine, histidine, β Alanine, 4-aminobutyric acid (GABA), betaine, L-cystine (L-Cyss), L-carnitine, L-citrulline, L-theanine, 3 ', 4'-dihydroxy-L-phenylalanine (L-dopa), 5'-hydroxy-L-tryptophan, L-homocysteine, S-methyl-L-methionine, S-allyl-L-cysteine-sulfoxide (L-alliin), L-trans-4-hydroxyproline, L-5-oxoproline ( L-pyroglutamic acid), L-phosphoserine, creatine, 3-methyl-L-histidine, L-ornithine, whereby both the individual amino acids and mixtures can be used.

Preferred care compositions according to the invention contain one or more amino acids in narrower ranges. Here, preferred cosmetic care compositions according to the invention are characterized in that they additionally contain from 0.05 to 5% by weight, preferably from 0.1 to 2.5% by weight, particularly preferably from 0.15 to 1% by weight and in particular from 0 , 2 to 0.5 wt .-% amino acid (s), preferably (one) amino acid (s) from the group glycine and / or alanine and / or valine and / or lysine and / or leucine and / or threonine.

• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Glycin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Alanin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Glucosemonohydrat und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Saccharose und 0,1 bis 0,25 Gew.-% Valin,
• – 0,005 bis 0,015 Gew.-% Coffein und 0,75 bis 1,5 Gew.-% Fructose und 0,1 bis 0,25 Gew.-% Valin.

Particularly preferred care compositions according to the invention contain based on their weight

• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of glycine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of alanine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of glucose monohydrate and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of sucrose and 0.1 to 0.25% by weight of valine,
• 0.005 to 0.015% by weight of caffeine and 0.75 to 1.5% by weight of fructose and 0.1 to 0.25% by weight of valine.

• i. es handelt sich um Substanzen botanischen, anorganisch-mineralischen oder tierischen Ursprungs (ausgenommen tote Wirbeltiere) sowie deren Gemische und Reaktionsprodukte untereinander (Naturstoffe), wobei für die Gewinnung und Weiterverarbeitung nur physikalische Verfahren, Mittel zur Einstellung des pH-Werts sowie enzymatische und mikrobiologische Verfahren, bei denen nur in der Natur vorkommende Enzyme oder Mikroorganismen verwendet werden, genutzt wurden;
• ii. es handelt sich um Substanzen, die durch eine oder mehrere der folgenden chemischen Reaktionen ausgehend von Naturstoffen erhalten wurden: Hydrolyse (einschl. Verseifung), Neutralisation, Kondensation unter Abspaltung von Wasser, Veresterung, Umesterung, Hydrierung, Hydrogenolyse, Dehydrierung, Glycosylierung, Phosphorylierung, Sulfatierung, Acylierung, Amidierung, Oxidation (mit Sauerstoff, Ozon und Peroxiden) und Pyrolyse.

Preferred care compositions are in the form of an emulsion, with O / W emulsions being preferred. Particularly preferred kits according to the invention are characterized in that the care composition contains 0.5 to 30 wt .-%, preferably 1 to 25 and in particular 2.5 to 10 wt .-% emulsifier (s) based on their weight, with preferred emulsifiers at least meet one of the following criteria:

• i. they are substances of botanical, inorganic-mineral or animal origin (except dead vertebrates) and their mixtures and reaction products with each other (natural products), with the recovery and further processing only physical methods, means for adjusting the pH and enzymatic and microbiological processes using only naturally occurring enzymes or microorganisms;
• ii. they are substances obtained by one or more of the following chemical reactions starting from natural products: hydrolysis (including saponification), neutralization, condensation with elimination of water, esterification, transesterification, hydrogenation, hydrogenolysis, dehydrogenation, glycosylation, phosphorylation, Sulfation, acylation, amidation, oxidation (with oxygen, ozone and peroxides) and pyrolysis.

• A) Bereitstellung einer in einem ersten Behälter verpackten Haarbehandlungszusammensetzung, die bezogen auf ihr Gewicht, zu mindestens 70 Gew.-%, vorzugsweise zu mindestens 75 Gew.-%, weiter bevorzugt zu mindestens 80 Gew.-%, besonders bevorzugt zu mindestens 85 Gew.-%, weiter bevorzugt zu mindestens 90 Gew.-% und insbesondere zu mindestens 99 Gew.-% aus Inhaltsstoffen besteht, die aus der Liste der in Anspruch 1 genannten Stoffe ausgewählt sind
• B) Bereitstellung einer in einem zweiten Behälter verpackten Pflegezusammensetzung, die bezogen auf ihr Gewicht mindestens 10 Gew.-% Pflegestoffe aus den Gruppen der quarternären Ammoniumverbindungen und/oder teriären Amine und/oder Silikone enthält,
• C) Vermischen der Zubereitungen und
• D) Applikation auf das Haar.

Another object of the present invention is a method for hair treatment, characterized by the steps

• A) providing a hair treatment composition packaged in a first container, based on its weight, at least 70 wt .-%, preferably at least 75 wt .-%, more preferably at least 80 wt .-%, particularly preferably at least 85 wt .-%, more preferably at least 90 wt .-% and in particular at least 99 wt .-% consists of ingredients that are selected from the list of substances mentioned in claim 1
• B) providing a care composition packaged in a second container which, based on its weight, contains at least 10% by weight of care substances from the groups of the quaternary ammonium compounds and / or teriary amines and / or silicones,
• C) mixing the preparations and
• D) application to the hair.

The mixing of the two compositions can be carried out in a container, alternatively, the mixing can also take place outside the container, for example in the hand or on the head of the user.

A preferred variant of the method according to the invention is characterized in that step C) takes place by adding care composition to the hair treatment composition in the first container.

In this case, the container in which the hair treatment composition is located is preferably sized to accommodate a portion or the total amount of care composition in the second container. After purchasing the kit according to the invention, the consumer mixes his hair treatment agent tailored to his individual needs and uses it from this point on like a normal product.

Alternatively, an individual mixture may be made prior to each application, for example, when the condition of the hair varies, or when more or less care is preferred on certain occasions. In particular, preferred herein are methods in which step C) by dosing a portion or the total amount of the hair treatment composition from the first container into the palm or head and adding a portion or the total amount of the care composition from the second container and then mixing in the hand or done on the head.

By the free dosage of the care composition, the degree of care of the hair treatment composition can be adjusted.

Examples:

Formulation examples for the hair treatment composition A in% by weight Aqua ad 100 Ammonium Lauryl Sulfate 8th glycerin 4 Sodium Cocoyl Glutamate 2 Coco-glucoside 2 Sodium stearoyl lactylate 1.2 Sodium Chloride 0.8 Benzoic Acid 0.2 Hydrolyzed rice protein 0.3 Formulation examples for the care composition B Data in% by weight Cyclomethicone 50 Aqua ad 100 Dimethiconol 8th Propylene glycol 2, Quaternium-80 2.0 Laureth-4 1.5 hydroxyethyl 1.5 Perfume 0.9 Aqua ad. 100 Cetearyl Alcohol 10 Dicocoylethyl hydroxyethylmonium methosulfate 1.5 Distearoylethyl hydroxyethylmonium methosulfate 1.5 Dicaprylyl ether 5 Behenoyl PG-Trimonium Chloride 5 Perfume 0.8 Trideceth-12 4 C12-14 SEC Pareth-5 1 Ceteth-10 1 Trideceth-10 1 amodimethicone * 5 * (Mirasil ADME, Belsil ADM, Dow Coming Q2 8220, Dow Corning 949) Aqua ad 100 Cetearyl Alcohol 10 Dimethicone 5 Isopropyl myristate 3 Behentrimonium chlorides 2 Stearamidopropyl dimethylamine 3 Cetrimonium chlorides 2 Aminopropyl phenyl trimethicone 1 Distearoylethyl hydroxyethylmonium methosulfate 2 Alcohol denate. 10 PEG / PPG-15/15 Dimethicone 8th PEG-7 amodimethicone 5 PEG-40 Hydrogenated Castor Oil 6 Aqua ad. 100

QUOTES INCLUDE IN THE DESCRIPTION

This list of the documents listed by the applicant has been generated automatically and is included solely for the better information of the reader. The list is not part of the German patent or utility model application. The DPMA assumes no liability for any errors or omissions.

Cited patent literature

• WO 92/13829 [0069]

Cited non-patent literature

• ISO standard 9235 [0017]

Claims (9)

Kit-of-parts, comprising A) a hair treatment composition packaged in a first container and B) a care composition packaged in a second container, characterized in that the hair treatment composition comprises at least 60% by weight of ingredients based on its weight are selected from the list of the following substances: - Acacia Decurrens / Jojoba / Sunflower - Algin Seed Wax / Polyglyceryl-3 Esters - alginic acid - Aluminum Stearate - Ammonium Alum - Ammonium Coco Sulfate - Ammonium glycyrrhizate - Ammonium Lauryl Sulfate - Anhydroxylitol - Arachidyl alcohol - Arachidyl glucosides - Arginine - ascorbic acid - ascorbyl dipalmitate - ascorbyl palmitate - Behenyl Alcohol - Behenyl Beeswax - Brassica Campestris / Aleurites Fordi Oil Copolymer C12-20 alkyl glucosides - C14-22 Alcohols - Calcium alginates - Calcium glycerophosphates - Calcium lactates - Caprylic / Capric triglycerides - Capryloyl Glycine - Caprylyl Caprylate - Caprylyl / caprylic glucosides - - cellulose - Ceramides - Cetearyl alcohol - Cetearyl glucosides - Cetearyl Olivate - Cetyl Alcohol - Cetyl palmitate - Cetyl ricinoleates - Chitosan - Chitosan Glycolate - chitosan lactate - Chitosan PCA - Cholesterol - Cholesteryl hydroxystearates - Cl 75470 - Cl 75810 - coco-glucosides - cocoglycerides - Coconut Alcohol - Corn Starch Modified - Cyclodextrin - Decyl Cocoate - Decyl glucosides - Decyl Oleate - Dehydroxanthan gum - Dextrin Palmitate - dicaprylyl ether - Dihydroxyacetones - dipalmitoylhydroxyproline - Disodium Coco-Glucosides Citrate - Disodium cocoyl glutamate - Distarch Phosphates - Erythrulose - Ethyl lactates - Gellan Gum - Glucose Glutamate - glycerin - Glyceryl Abietate - Glyceryl behenate - Glyceryl caprate - Glyceryl caprylates - glyceryl Citrate / Lactate / linoleate / oleate - Glyceryl dibehenate - Glyceryl dioleate - Glyceryl distearate - Glyceryl glucosides - Glyceryl lactates - glyceryl laurate - Glyceryl linoleates - Glyceryl linolenates - Glyceryl Oleate - Glyceryl Oleate Citrate - Glyceryl ricinoleates - Glyceryl sorbitan oleostearates - Glyceryl Stearate - Glyceryl Stearate Citrate - Glyceryl Stearate SE - Glycyrrhetinic acid - Hydrogenated Apricot Kernel Oil - Hydrogenated Castor Oil - Hydrogenated Coco-Glycerides - Hydrogenated Coconut Oil - Hydrogenated Jojoba Oil - Hydrogenated Jojoba Wax - Hydrogenated lecithin - Hydrogenated Meadowfoam Seed oil - Hydrogenated Olive Oil - Hydrogenated Palm Glycerides - Hydrogenated Palm Glycerides Citrate - Hydrogenated Palm Kernel Glycerides - Hydrogenated Palm Oil - Hydrogenated Peanut Oil - Hydrogenated phosphatidylcholines - Hydrogenated Rapeseed Oil - Hydrogenated Vegetable Oil - Hydrolyzed Algae Extract - Hydrolyzed Beeswax - Hydrolyzed fibroin - Hydrolyzed Hibiscus Esculentus - Hydrolyzed Jojoba Esters Extract - Hydrolyzed keratin - Hydrolyzed Lola Implexa Extract - Hydrolyzed Milk Protein - Hydrolyzed Rhizobian Gum - Hydrolyzed rice protein - Hydrolyzed Silk - Hydrolyzed soy protein - Hydrolyzed Sweet Almond protein - Hydrolyzed Wheat Gluten - Hydrolyzed Wheat Protein - Hydroxystearic / Linolenic / Linoleic - Hydroxystearic / Linolenic / Oleic Polyglycerides Polyglycerides - Isoamyl Laurate - Isostearyl hydroxystearates - Jojoba Esters - Lanolin Alcohol - lauroyl lysine - Lauryl Alcohol - Lauryl Glucoside - Lauryl Lactates - Lauryl Laurate - Lauryl PCA - levulinic acid - lysolecithin - Magnesium ascorbyl phosphate - Magnesium Gluconate - Magnesium Stearate - Maltitol - maltodextrin - mannitol - menthanediol - - Microcrystalline cellulose - Myristic acid - myristyl alcohol - myristyl glucoside - myristyl lactate - myristyl myristate - Octyl dodecanol - Oleyl Alcohol - oleyl erucate - Oryzanol - Palm Kernel Acid - Palmitic Acid - Palmityl Alcohol P-anisic acid - PCA - PCA Ethyl Cocoyl Arginate - PCA Glyceryl Oleate - phytosteryl / octyldodecyl Lauroyl Glutamate Polyglyceryl-10 Laurate - Polyglyceryl-2 caprate - Polyglyceryl-2 dipolyhydroxystearates - polyglyceryl-2 polyhydroxystearate - Polyglyceryl-3-caprylates - Polyglyceryl-3 diisostearate Polyglyceryl-3 Laurate - Polyglyceryl-3 oleates - Polyglyceryl-3 palmitates - Polyglyceryl-3 Polyricinoleates - Polyglyceryl-3 ricinoleates - Polyglyceryl-3 stearates - Polyglyceryl-4 Caprate Polyglyceryl-5 Laurate - Polyglyceryl-5 oleates - Polyglyceryl-6-caprylates - Polyglyceryl-6 dicaprate - Polyglyceryl-6 oleates - polyglyceryl-6 stearates - Potassium Cetyl Phosphate - Potassium Cocoate - Potassium Laurate - Potassium myristate - Potassium Olivate - Potassium Palmitate - Potassium Palmitoyl Hydrolyzed Wheat Protein - Potassium Stearate - saccharides isomerates - Sodium alginate - Sodium anisate - Sodium Beeswax - Sodium Cetearyl Sulfate - Sodium Cocoate - Sodium Coco-Glucoside tartrate - Sodium cocopolyglucose tartrate - Sodium coco sulphate - Sodium cocoyl alaninate - Sodium Cocoyl Amino Acids - Sodium Cocoyl Glutamate - Sodium Cocoyl Hydrolyzed Wheat protein - Sodium Lauroyl Glutamate - Sodium Lauroyl Lactylate - Sodium Lauryl Sulfate - Sodium Levulinate - Sodium myristate - Sodium myristoyl glutamate - Sodium Oleanolate - Sodium Olivate - Sodium Palm Kernelate - Sodium Palmate - Sodium Palmitate - Sodium PCA - Sodium Phytate - Sodium stearate - Sodium stearoyl glutamate - Sodium stearoyl lactylate - Sodium Tallowate - Sodium Ursolate - Sorbitan Laurate - Sorbitan Oleate - Sorbitan Olivate - Sorbitan Palmitate - sorbitan sesquicaprylate - Sorbitan Stearate - sorbitol - soybean glycerides - Squalane - Squalene - Stearic acid - Stearyl alcohol - stearyl beeswax - sucrose cocoate - Sucrose distearate - sucrose laurate - sucrose palmitate - sucrose polystearates - sucrose stearate - sucrose tristearate - Sulfated Castor Oil - Sunflower Seed Sorbitol Esters - tocopheryl acetate - Tribehenin - tricaprylin - triethyl citrate - undecylenic acid - Water - xylitol - xylitylglucosides - Zinc Citrate - Zinc PCA - Zinc Ricinoleate - Zinc Stearate - The care composition based on their weight at least 10 wt .-% care agents from the groups of - quaternary ammonium compounds and / or - teriary amines and / or - silicones. Kit according to claim 1, characterized in that the hair treatment composition based on its weight to at least 70 wt .-%, preferably at least 75 wt .-%, more preferably at least 80 wt .-%, particularly preferably at least 85 wt. %, more preferably at least 90 wt .-% and in particular at least 99 wt .-% consists of ingredients that are selected from the list of substances mentioned in claim 1. Kit according to one of claims 1 or 2, characterized in that the care composition based on their weight from 2.5 to 60 wt .-%, preferably 5 to 50 and in particular 10 to 40 wt .-% silicone (s). Kit according to one of claims 1 to 3, characterized in that the care composition based on their weight from 0.5 to 30 wt .-%, preferably 1 to 25 and in particular 2.5 to 10 wt .-% quartenary ammonium compound (s) , Kit according to one of claims 1 to 4, characterized in that the care composition QAV of the formula (I) R ^I ₂ N ⁺ (R ^II ) _x (R ^II ) _y X ^- (I) contains, in the R ^I for long-chain fatty acid residues, preferably stearoyl or cocoyl, R ^{II is} an alkyl radical, preferably (CH ₂ ) _n CH ₃ , R ^{III is} a hydroxyalkyl radical, preferably (CH ₂ CH ₂ OH), n is a integer, preferably 2, x and y are 0, 1 or 2, where x + y = 2 and X is an anion, preferably methosulfate. Kit according to one of claims 1 to 5, characterized in that the care composition contains by weight 0.5 to 30 wt .-%, preferably 1 to 25 and in particular 2.5 to 10 wt .-% emulsifier (s), preferred emulsifiers meeting at least one of the following criteria: iii. they are substances of botanical, inorganic-mineral or animal origin (except dead vertebrates) and their mixtures and reaction products with each other (natural products), with the recovery and further processing only physical processes, means for adjusting the pH and enzymatic and microbiological processes using only naturally occurring enzymes or microorganisms have been used; iv. they are substances obtained by one or more of the following chemical reactions starting from natural products: hydrolysis (including saponification), neutralization, condensation with elimination of water, esterification, transesterification, hydrogenation, hydrogenolysis, dehydrogenation, glycosylation, phosphorylation, Sulfation, acylation, amidation, oxidation (with oxygen, ozone and peroxides) and pyrolysis. Hair treatment process characterized by the steps A) providing a hair treatment composition packaged in a first container, based on its weight, at least 70 wt .-%, preferably at least 75 wt .-%, more preferably at least 80 wt .-%, particularly preferably at least 85 wt .-%, more preferably at least 90 wt .-% and in particular at least 99 wt .-% consists of ingredients that are selected from the list of substances mentioned in claim 1 B) providing a care composition packaged in a second container which, based on its weight, contains at least 10% by weight of care substances from the groups of the quaternary ammonium compounds and / or teriary amines and / or silicones, C) mixing the preparations and D) application to the hair. A method according to claim 7, characterized in that step C) is carried out by adding care composition to the hair treatment composition in the first container. A method according to claim 7, characterized in that step C) by dosing a portion or the total amount of the hair treatment composition from the first container in the palm or on the head and adding a part or the total amount of the care composition from the second container and subsequent mixing in the Done by hand or on the head.